Skip to content
Catholic Online Logo

By Catholic Online (NEWS CONSORTIUM)

1/10/2013 (2 years ago)

Catholic Online (www.catholic.org)

Scientist report remarkable success with laboratory mice

An exciting new drug could quickly become the first oral medication that could help the paralyzed to walk again. Scientists have reported remarkable success mice who previously had no movement in their lower limbs to walk again with "well-coordinated steps" and even to replicate swimming motions.

The small molecule in the study was tested for its ability to prevent the death of cells called oligodendrocytes, which surround and protect axons, long projections of a nerve cell, by wrapping them in a myelin sheath that protects the fibers.

The small molecule in the study was tested for its ability to prevent the death of cells called oligodendrocytes, which surround and protect axons, long projections of a nerve cell, by wrapping them in a myelin sheath that protects the fibers.

Highlights

By Catholic Online (NEWS CONSORTIUM)

Catholic Online (www.catholic.org)

1/10/2013 (2 years ago)

Published in Health

Keywords: Paralysis, drug, experiemnt, lab animals, oligodendrocytes


LOS ANGELES, CA (Catholic online) - The experimental medication also didn't increase pain in the mice and showed no toxic effects. The medication also efficiently crossed the blood brain barrier, which protects the central nervous system from potentially harmful chemicals carried around in the rest of the bloodstream.

"This is a first to have a drug that can be taken orally to produce functional improvement with no toxicity in a rodent model," Professor Sung Ok Yoon of Ohio State University Columbus says.

"So far, in the spinal cord injury field with rodent models, effective treatments have included more than one therapy, often involving invasive means. Here, with a single agent, we were able to obtain functional improvement."

The small molecule in the study was tested for its ability to prevent the death of cells called oligodendrocytes, which surround and protect axons, long projections of a nerve cell, by wrapping them in a myelin sheath that protects the fibers.

The drug then preserved oligodendrocytes by inhibiting the activation of a protein called p75. Yoon's lab previously found p75 is linked to the death of these specialized cells after a spinal cord injury. When they die, axons that are supported by them degenerate.

"Because we know oligodendrocytes continue to die for a long period of time after an injury, we took the approach that if we could put a brake on that cell death, we could prevent continued degeneration of axons.

"Many researchers in the field are focusing on regeneration of neurons, but we specifically targeted a different type of cell because it allows a relatively long therapeutic window."

The current treatment for humans, methylprednisolone must be administered within eight but not after 24 hours after the injury to be effective at all.

An estimated 1.3 million people in the United States are living with spinal cord injuries, experiencing paralysis and complications that include bladder, bowel and sexual dysfunction and chronic pain.

Called LM11A-31, the experimental drug was developed by Professor Frank Longo, of Stanford University, California.

The researchers gave three different oral doses of LM11A-31 in addition to a placebo, to different groups of mice starting four hours after injury and then twice daily for a 42 day experimental period.

The scientists analyzed the compound's effectiveness at improving limb movement and preventing myelin loss.

The spinal cord injuries in mice mimicked those caused in humans by the application of extensive force and pressure, resulting in loss of hind limb and bladder function and difficulty in walking and swimming.

The researchers determined the mice did not experience more pain than the placebo group at all the doses tested, suggesting LM11A-31 does not worsen nerve pain after spinal cord injury.

---


Pope Francis: end world hunger through 'Prayer and Action'


Copywriter 2015 - Distributed by THE NEWS CONSORTIUM

Pope Francis Prayer Intentions for March 2015
Universal:
Scientists: That those involved in scientific research may serve the well-being of the whole human person.
Evangelization: Contribution of women: That the unique contribution of women to the life of the Church may be recognized always.


Rosaries, Crosses, Prayer Cards and more... by Catholic Shopping .com


Comments


More Health

Negative relationships really are unhealthy: New research shows high blood pressure linked to stressful relationships Watch

Image of

By Atarah Haely (NEWS CONSORTIUM)

Bad relationship status may cause physiological health deterioration. The research, conducted by a team from the University of Michigan, discovered men are more sensitive with regards to the stress levels of their wives or partners. These stress levels, from negative ... continue reading


Killer high heels cause long lasting body damage Watch

Image of

By Nikky Andres (NEWS CONSORTIUM)

Fashion is such a big thing, especially for women. These days, for you to belong to the "it-crowd," you have to be stylish and popular in your social media posts, or you constantly have to update your fashion blog with the latest trends in clothing, shoes, and ... continue reading


Divorce, other stressful events may possibly trigger diabetes in children Watch

Image of The study said that while the causes of type 1 diabetes are unknown, it is usually preceded by the body's own immune system attacking and killing beta cells in the pancreas, which produce insulin.

By Catholic Online (NEWS CONSORTIUM)

A new study conducted in Sweden has found that traumatic events experienced in childhood - such as the divorce of parents, death or illness increases the risk of developing type 1 diabetes in children. LOS ANGELES, CA (Catholic Online) - The Swedish study ... continue reading


Rare deadly tick borne virus is worse than Lyme disease Watch

Image of

By Hannah Raissa Marfil (NEWS CONSORTIUM)

The Powassan virus, though having similar symptoms, are even worse than the Lyme disease, according to doctors. This tick borne virus is rare and potentially life-threatening, without any cure or treatment known of yet, reported by the CBS2. In a matter of minutes ... continue reading


First human head transplant to be performed by doctor critics call 'nuts' Watch

Image of Valery Spiridonov plans on being the first recipient to a human head transplant (East2WestNews).

By Hannah Raissa Marfil (NEWS CONSORTIUM)

Suffering from the rare genetic Werdnig-Hoffman muscle wasting disease, diagnosed when he was one, Valery Spiridonov says that he is ready to undergo the first human head transplant. MUNTINLUPA, PHILIPPINES (Catholic Online) - The 30-year-old Russian computer scientist ... continue reading


Is Facebook making you depressed? Recent study finds link between Facebook and depression Watch

Image of Facebook enables people to share their lives online which also allows users to see information about their friends that they don't normally have access to.

By Hannah Raissa Marfil (NEWS CONSORTIUM)

Researchers have discovered that Facebook users who spend more time in social media tend to compare their own lives from their friends', resulting into occurrence of depressive symptoms, according to a new study from the University of Houston. The danger lies in the ... continue reading


Man reveals secret on how he lost nearly 400 pounds Watch

Image of Brian Flemming only has 30 to 40 pounds left to go to reach his goal, and that's in excess skin.

By Hannah Raissa Marfil (NEWS CONSORTIUM)

With just 30 to 40 pounds of excess skin left for him to undergo surgery, Brian Flemming was successful in shedding out almost 400 pounds. He recently showed off his body in front of a camera, gaining enough attention to become a headline. Previously weighing 625 ... continue reading


Over diagnosed? Doctors now say that two-thirds of the people on anti-depressants may not need them Watch

Image of Medication for anxiety and medication is being prescribed to patients that are not clinically depressed, researchers say.

By Catholic Online (NEWS CONSORTIUM)

In an increasingly tense society, many doctors are handing out prescriptions for drugs that enable patients to combat feelings of moodiness and depression. Researchers now say that more than two-thirds, or 69 percent of people taking antidepressants don't meet ... continue reading


Mayo Clinic discovers mystery disease destroying lawyer Watch

Image of

By Hannah Raissa Marfil (NEWS CONSORTIUM)

Greg Widseth, a lawyer from Minnesota, had been suffering from an unknown disease. Neurologists he had visited could not figure out what was happening to him. Fortunately for Widseth, Mayo Clinic has been able to determine the neurological disease wreaking havoc on ... continue reading


Ancient remedy using natural ingredients appears to stop 'superbug' Watch

Image of Modern researchers are researching why the salve works so effectively.

By Catholic Online (NEWS CONSORTIUM)

Methicillin-resistant Staphylococcus aureus, or MRSA, a flesh infection usually transmitted over lengthy hospital stays, may have met its match in an ancient, medieval potion that uses only natural ingredients. The seemingly magical potion, which contains ... continue reading


All Health News

Newsletters

Newsletter Sign Up icon

Stay up to date with the latest news, information, and special offers

Daily Readings

Reading 1, Acts 6:1-7
1 About this time, when the number of disciples was ... Read More

Psalm, Psalms 33:1-2, 4-5, 18-19
4 The word of Yahweh is straightforward, all he does ... Read More

Gospel, Luke 24:35-48
16 That evening the disciples went down to the shore ... Read More

Saint of the Day

Saint of the Day for April 18th, 2015 Image

St. Apollonius the Apologist
April 18: Martyr whose Apologia, or defense of the faith, is considered ... Read More

Inform, Inspire & Ignite Logo

Find Catholic Online on Facebook and get updates right in your live feed.

Become a fan of Catholic Online on Facebook


Follow Catholic Online on Twitter and get News and Product updates.

Follow us on Twitter